102 related articles for article (PubMed ID: 20646482)
1. [Arginine-glycine-aspartic polypeptide mediated truncated tissue factor therapy for colorectal carcinoma].
Huang ZJ; Luo Q; Yan JH; Wang SY
Zhonghua Wai Ke Za Zhi; 2010 Apr; 48(8):619-24. PubMed ID: 20646482
[TBL] [Abstract][Full Text] [Related]
2. [Humanized monoclonal antibody TNT-3-mediated truncated tissue factor for the treatment of H22 hepatoma-bearing mice].
Huang ZJ; Wang R; Liu ZZ; Wang SY; Yan JH; Luo Q
Zhonghua Zhong Liu Za Zhi; 2012 Apr; 34(4):249-53. PubMed ID: 22781034
[TBL] [Abstract][Full Text] [Related]
3. Tissue-factor fusion proteins induce occlusion of tumor vessels.
Schwöppe C; Kessler T; Persigehl T; Liersch R; Hintelmann H; Dreischalück J; Ring J; Bremer C; Heindel W; Mesters RM; Berdel WE
Thromb Res; 2010 Apr; 125 Suppl 2():S143-50. PubMed ID: 20433995
[TBL] [Abstract][Full Text] [Related]
4. Targeting the vasculature of colorectal carcinoma with a fused protein of (RGD)₃-tTF.
Huang ZJ; Zhao Y; Luo WY; You J; Li SW; Yi WC; Wang SY; Yan JH; Luo Q
ScientificWorldJournal; 2013; 2013():637086. PubMed ID: 23861656
[TBL] [Abstract][Full Text] [Related]
5. [Gene expression and activities analysis of a new fusion protein (RGD) 3/tTF].
Yan JH; Yang GW; Wang JP; Wu N; Zhuang GH
Sheng Wu Gong Cheng Xue Bao; 2007 May; 23(3):409-12. PubMed ID: 17577984
[TBL] [Abstract][Full Text] [Related]
6. Comparison of three different targeted tissue factor fusion proteins for inducing tumor vessel thrombosis.
Hu P; Yan J; Sharifi J; Bai T; Khawli LA; Epstein AL
Cancer Res; 2003 Aug; 63(16):5046-53. PubMed ID: 12941833
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of tumor growth by RGD peptide-directed delivery of truncated tissue factor to the tumor vasculature.
Kessler T; Bieker R; Padró T; Schwöppe C; Persigehl T; Bremer C; Kreuter M; Berdel WE; Mesters RM
Clin Cancer Res; 2005 Sep; 11(17):6317-24. PubMed ID: 16144936
[TBL] [Abstract][Full Text] [Related]
8. [Expression and characterization of fusion protein tTF/SA as a universal effector for targeting blood coagulation].
Wang Z; Yan JH; Wang JP; Xie LY; Wu N
Sheng Wu Gong Cheng Xue Bao; 2007 Mar; 23(2):218-22. PubMed ID: 17460891
[TBL] [Abstract][Full Text] [Related]
9. Tumor Growth Inhibition via Occlusion of Tumor Vasculature Induced by N-Terminally PEGylated Retargeted Tissue Factor tTF-NGR.
Brand C; Fröhlich M; Ring J; Schliemann C; Kessler T; Mantke V; König S; Lücke M; Mesters RM; Berdel WE; Schwöppe C
Mol Pharm; 2015 Oct; 12(10):3749-58. PubMed ID: 26310827
[TBL] [Abstract][Full Text] [Related]
10. NG2 proteoglycan as a pericyte target for anticancer therapy by tumor vessel infarction with retargeted tissue factor.
Brand C; Schliemann C; Ring J; Kessler T; Bäumer S; Angenendt L; Mantke V; Ross R; Hintelmann H; Spieker T; Wardelmann E; Mesters RM; Berdel WE; Schwöppe C
Oncotarget; 2016 Feb; 7(6):6774-89. PubMed ID: 26735180
[TBL] [Abstract][Full Text] [Related]
11. Generation of fusion proteins for selective occlusion of tumor vessels.
Kessler T; Schwöppe C; Liersch R; Schliemann C; Hintelmann H; Bieker R; Berdel WE; Mesters RM
Curr Drug Discov Technol; 2008 Mar; 5(1):1-8. PubMed ID: 18537561
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive monitoring of tumor-vessel infarction by retargeted truncated tissue factor tTF-NGR using multi-modal imaging.
Persigehl T; Ring J; Bremer C; Heindel W; Holtmeier R; Stypmann J; Claesener M; Hermann S; Schäfers M; Zerbst C; Schliemann C; Mesters RM; Berdel WE; Schwöppe C
Angiogenesis; 2014 Jan; 17(1):235-46. PubMed ID: 24136410
[TBL] [Abstract][Full Text] [Related]
13. Antitumor effect and mechanism of action of a tumor-targeting recombinant human tumor necrosis factor-α fusion protein mediated by urokinase.
Dai YC; Yang SM; Wang X; Zhou YJ; Hou G; Huang DN
Mol Med Rep; 2015 Jun; 11(6):4333-40. PubMed ID: 25672264
[TBL] [Abstract][Full Text] [Related]
14. Fusion protein tTF-EG3287 induces occlusion of tumor vessels and impairs tumor growth in human colon caner.
Qiu GQ; Xie X; Zhao B; Xu LZ; Chen YQ
Neoplasma; 2019 Mar; 66(2):252-260. PubMed ID: 30569722
[TBL] [Abstract][Full Text] [Related]
15. A recombined fusion protein SP5.2/tTF induce thrombosis in tumor blood vessel.
Lv S; Ye M; Wang X; Li Z; Chen X; Dou X; Dai Y; Zeng F; Luo L; Wang C; Li K; Luo X; Yan J; Li X
Neoplasma; 2015; 62(4):531-40. PubMed ID: 25997964
[TBL] [Abstract][Full Text] [Related]
16. Antitumor Effect of Nanoparticle
Ming H; Fang L; Gao J; Li C; Ji Y; Shen Y; Hu Y; Li N; Chang J; Li W; Tan J
AJR Am J Roentgenol; 2017 May; 208(5):1116-1126. PubMed ID: 28301223
[TBL] [Abstract][Full Text] [Related]
17. The use of the fusion protein RGD-HSA-TIMP2 as a tumor targeting imaging probe for SPECT and PET.
Choi N; Kim SM; Hong KS; Cho G; Cho JH; Lee C; Ryu EK
Biomaterials; 2011 Oct; 32(29):7151-8. PubMed ID: 21719102
[TBL] [Abstract][Full Text] [Related]
18. A fusion protein containing murine vascular endothelial growth factor and tissue factor induces thrombogenesis and suppression of tumor growth in a colon carcinoma model.
Huang FY; Li YN; Wang H; Huang YH; Lin YY; Tan GH
J Zhejiang Univ Sci B; 2008 Aug; 9(8):602-9. PubMed ID: 18763309
[TBL] [Abstract][Full Text] [Related]
19. [The efficacy of autocatalytic casapse-3 driven by human telomerase reverse transcriptase promoter on human ovarian carcinoma].
Song Y; Shen K; Yu JR
Zhonghua Yi Xue Za Zhi; 2007 Nov; 87(41):2919-24. PubMed ID: 18261307
[TBL] [Abstract][Full Text] [Related]
20. Expression and purification of rhIL-10-RGD from Escherichia coli as a potential wound healing agent.
Yang F; Wan Y; Liu J; Yang X; Wang H; Tao K; Han J; Shi J; Hu D
J Microbiol Methods; 2016 Aug; 127():62-67. PubMed ID: 27241829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
